Core Viewpoint - Tongyuan Kang Pharmaceutical-B (02410.HK) has received a Drug Manufacturing License from the Zhejiang Provincial Drug Administration, which is expected to positively impact the company's capacity expansion and market development in the long term [1]. Group 1: License Details - The company, Zhejiang Tongyuan Kang Pharmaceutical Co., Ltd., is registered at 1278 Mingzhu Road, Changxing Economic Development Zone, Huzhou, Zhejiang Province [1]. - The production address is entrusted to Kailaiying Life Science Technology (Tianjin) Co., Ltd., located at No. 71, Seventh Avenue, Tianjin Economic Development Zone [1]. - The license number is Zhe20260002, valid until January 22, 2031, issued by the Zhejiang Provincial Drug Administration [1]. Group 2: Implications of the License - The acquisition of the Drug Manufacturing License is anticipated to lay the foundation for the company to commence commercial production [1]. - This development is expected to provide better treatment options for patients, addressing urgent medical needs in cancer treatment [1].
同源康医药-B(02410.HK)获浙江省药品监督管理局颁发《药品生产许可证》